发明名称 CD44 SPLICE VARIANTS IN NEURODEGENERATIVE DISEASES
摘要 <p>There is provided a method of treating or preventing a neurodegenerative disease, which includes administration of a composition that includes a reagent capable of modulating expression of ribonucleic acid (RNA) encoded by a nucleic acid, wherein the nucleic acid is selected from a group that includes a contiguous nucleotide sequence being at least 90% homologous to at least 20 nucleotides of: SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, or any combination thereof. There is further provided a method of treating or preventing a neurodegenerative disease, which includes administration of a composition that includes a reagent capable of modulating expression and/or activity of a polypeptide, wherein the sequence of the polypeptide is selected from a group that includes a contiguous amino acid sequence being at least 90% homologous to at least 10 amino acid of: SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, or any combination thereof.</p>
申请公布号 HK1145856(A1) 申请公布日期 2014.06.06
申请号 HK20110100082 申请日期 2011.01.06
申请人 NEURIM PHARMACEUTICALS (1991) LTD. 发明人 PINNER, ELHANAN;LAUDON, MOSHE;ZISAPEL, NAVA
分类号 C12Q 主分类号 C12Q
代理机构 代理人
主权项
地址